Patent Law

The ABA Section of Intellectual Property Law in cooperation with the ABA Section of Science & Technology Law and the ABA Forum on the Entertainment & Sports Industries will host the 25th Annual Intellectual Property Law Conference on April 7 - 10, 2010 in Arlington, Virginia.

Pick up an entire year?s worth of CLE credits during the 2 ½ days of quality IP programming on the issues critical to your practice. Some program highlights include:

?The future of patent reform

?ITC IP mediation project

?Google books settlement

?Defending depositions in trademark cases

?Duty of disclosure to USPTO

?Patent damages

?Opinion of counsel

?Legal aspects of social media marketing

?Biosimilars

?Venue transfer & forum selection

?Interfacing with clients

The conference will also feature ample opportunities to network with your IP colleagues, whether at our Young Lawyers Welcome Reception, Corporate Counsel Reception, Women?s Networking Dinner, or the popular reception at the Dolley Madison House at the U.S. Court of Appeals for the Federal Circuit. In addition, a very special 25th Anniversary Gala Dinner with entertainment and dancing is planned to fete a quarter century of this preeminent conference.

The program will feature:

• Hon. Paul R. Michel, Chief Judge, U.S. Court of Appeals for the Federal Circuit
• Hon. Michael R. Fleming, Chief Administrative Patent Judge, Board of Patent Appeals and Interferences, U.S. Patent and Trademark Office
• Hon. Paul J. Luckern, Chief Administrative Law Judge, U.S. International Trade Commission
• Robert L. Stoll, Commissioner for Patents, U.S. Patent and Trademark Office
• Matthew Bryan, Director, Office of the PCT, World Intellectual Property Organization
• Maria Pallente, Associate Register for Policy & International Affairs, U.S. Copyright Office
• David L. Marcus, Chief Patent Counsel, Comcast Corp.
• Jennifer Granick, Civil Liberties Director, Electronic Frontier Foundation
• Randy Milch, General Counsel, Verizon Communications
• Elizabeth Dickinson, Associate Chief Counsel for Drugs, Food and Drug Administration
• Philip S. Johnson, Johnson & Johnson
• Fabricio Vayra, Time Warner

A brochure and registration details are available here.